FDA Approves TOFACITINIB — Zydus Pharmaceuticals USA Inc.
Zydus Pharmaceuticals USA Inc. secured FDA approval for its generic version of Tofacitinib Citrate, positioning the firm to capture significant market share and drive additional revenue as it enters the competitive oral treatment landscape.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day